NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neuromod Devices

Neuromod Devices

Private
DublinHealthcare & Life Scienceshttps://neuromoddevices.com

Last Round

Series B

Extension

Mar 11, 2025

Total Funding Raised

$62.32M

Company Overview

Neuromod Devices is a medical device company that specializes in the design and development of neuromodulation technologies to address the clinical needs of people living with chronic and debilitating conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

tinnitus treatmentbimodal neuromodulationtinnitus deviceneuromodulationmedical deviceFDA approved devicenon-invasive treatmenttongue stimulationat-home medical devicemedical technologyaudiologyENTveteran healthcareB2B2CCE Mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuromod Devices Comparables

Compare Neuromod Devices with similar companies based on industry and business-model similarity.

Neuromod Devices comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Auricle
85%
Otoharmonics Corporation
79%
Duearity
73%

Neuromod Devices Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 11, 2025
Series BApr 13, 2023
DebtApr 13, 2023
Series BOct 20, 2020
VC RoundSep 26, 2019
Series A
Sep 29, 2015

Key People

Founding team and executive leadership

Eric Timm

President, Global Commercial Operations & CEO Neuromod USA

Executive Team

Ross O'Neill

Founder & CEO

Founding Team

Florian Elsaesser

Chief Financial Officer

Executive Team

Stephanie Glowacki

Chief Financial Officer

Executive Team

Neuromod Devices Investors

Notable investors and investment history

Neuromod Devices investors
InvestorRounds
Kreos CapitalSeries B, VC Round
Fountain Healthcare PartnersSeries B, VC Round, Series A, Series B Extension
European Investment Bank GroupDebt, Series B
Panakès PartnersSeries B, Series B Extension
Silicon Valley BankSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2025

    $11M round led by Fountain Healthcare Partners and Panakès Partners.

  • Jul 13, 2024

    Grew 15% QoQ, from 52 to 60 employees.

Neuromod Devices Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuromod Devices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuromod Devices's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range66
Year Founded2010
Last FundingMar 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.